{"id":"W4416658298","doi":"10.5256/f1000research.153058.r196057","title":"Referee report. For: The identification of high-performing antibodies for Charged multivesicular body protein 2b for use in Western Blot, immunoprecipitation and immunofluorescence [version 1; peer review: 2 approved]","year":2023,"lang":"en","type":"article","venue":"Faculty of 1000 Research Ltd","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Genentech; Government of Canada; Ontario Genomics Institute; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Mitacs; Ontario Genomics; Genome Canada; Bayer; Motor Neurone Disease Association; Pfizer; Bristol-Myers Squibb","keywords":"Immunoprecipitation; Immunofluorescence; Identification (biology); Antibody; Indirect immunofluorescence; Blot","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"medium","status":"direct model label, unvalidated"}],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005737317,0.0007991833,0.001282644,0.002715053,0.003479345,0.00275345,0.002408043,0.005709845,0.487087],"category_scores_gemma":[0.07021559,0.0005080093,0.001133883,0.002088214,0.0007172245,0.002150165,0.002577946,0.004011204,0.26617],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003600074,"about_ca_system_score_gemma":0.004933522,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02827687,"about_ca_topic_score_gemma":0.04319749,"domain_scores_codex":[0.9956486,0.0005816392,0.0005072035,0.0005647439,0.002357205,0.0003406714],"domain_scores_gemma":[0.9239208,0.0105524,0.00111191,0.003399439,0.05857322,0.002442288],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0000118925,0.00001168054,0.00005785994,0.00003869945,0.000002407727,0.00005259212,0.0000188334,0.000007433492,0.0001477945,0.0003181326,0.9955603,0.003772282],"study_design_scores_gemma":[0.00002405998,0.00001572143,0.00121871,0.00008415178,0.0000105013,0.0001703618,0.0001373957,0.00008967689,0.0004263259,0.001139427,0.9966491,0.00003461314],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"editorial","genre_gemma":"commentary","genre_scores_codex":[0.001291031,0.003105878,0.006724871,0.3926715,0.3951631,0.002145551,0.03621557,0.005421055,0.1572614],"genre_scores_gemma":[0.008591093,0.00220318,0.006140422,0.08500966,0.03834666,0.001115794,0.01110545,0.00184517,0.8456426],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.487087,"threshold_uncertainty_score":0.7316082,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08403497584241056,"score_gpt":0.408225091497139,"score_spread":0.3241901156547285,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}